Showing 1-5 of 33 resources:
Feb 28 – Outcomes as a Pathway for Payer-Pharma-Provider Collaboration

February 28, 2018 – 2:00 pm – 3:00 pm ET Join Dr. Richard Gliklich, CEO of OM1, to explore the opportunities with using big data, predictive analytics and measurable outcomes to develop and implement outcomes based programs that align stakeholder incentives around benefits and costs.  Discussion will include: Using standardized outcomes measurement Predicting treatment benefit,[…]

OM1 Makes List of Top 50 Startups

Built In Boston’s 50 Startups to Watch in 2018 Published on Built In Boston January 16, 2018 Boston’s tech sector continued to blossom in 2017, as startups launched in virtually every industry — from cybersecurity to robotics and everything in between. Meanwhile, venture capital firms continued to pour money into the city’s legacy industries, including[…]

Artificial Intelligence for Real-World Evidence

Published on HealthEconomics.com on January 3, 2018   As artificial intelligence (AI) and Big Data are lauded for their potential uses in life sciences and healthcare, it is becoming difficult to differentiate between the myriad of terms and technologies and their real value in advancing real-world evidence (RWE).   In this article, we explore key AI[…]

AI & Big Data: Transforming Real-World Evidence’s Impact on Decision Making

November 28, 2017 – Dr. Richard Gliklich As artificial intelligence and advanced analytics are increasingly lauded for uses in life sciences and healthcare, it’s becoming difficult to differentiate between the different terms, to understand what is real and what is hype, and to understand how to best leverage these technologies for advancing real-world evidence and[…]

1 2 3 7